The Newburger-Bellinger Cardiac Neurodevelopmental Award was established in 2013 by the Cardiac Neurodevelopmental Outcome Collaborative to honor Jane Newburger and David Bellinger, pioneers in research designed to understand and improve neurodevelopmental outcomes for children with heart disease. The award is presented annually at the Scientific Sessions of the Cardiac Neurodevelopmental Outcome Collaborative.
Newburger-Bellinger Cardiac Neurodevelopmental Award
NOMINATIONS ACCEPTED between January 15 and March 16, 2020.
Criteria for nomination: A cardiologist, surgeon, anesthesiologist, neurologist, developmental pediatrician, geneticist, psychologist, nurse, PhD researcher, or other neurodevelopmental professional who has made significant contributions to clinical care, research knowledge, teaching or community advocacy leading to improvements in the neurodevelopmental outcomes of children with heart disease. Please forward this page to other colleagues who may be interested. Membership in CNOC is not a factor.
Submit a letter of support that details the nominee’s significant contribution to Kelly Wolfe, CNOC Secretary. All letters of nomination will be reviewed by the Steering Committee, and all nominees notified by April 1. The selected award recipient will deliver a keynote address during the 9th Annual Scientific Sessions of the Cardiac Neurodevelopmental Outcome Collaborative in Houston, Texas, October 22-25, 2020.
2019 Recipient – Richard A. Jonas MD
Dr. Jonas has been the chief of cardiac surgery and co-director of the Children’s National Heart Institute in Washington DC since 2004. He previously spent 20 years on staff at Children’s Hospital Boston including 10 years as department chief and the William E. Ladd Chair of Surgery at Harvard Medical School.
Dr. Jonas’ interest in neurodevelopment following cardiac surgery began with studies in the Harvard psychology department developing rodent models of ischemic brain injury. He subsequently undertook a series of highly productive piglet cardiopulmonary bypass studies at the National Magnet Laboratory at MIT. These studies suggested that the techniques of bypass used at the time were suboptimal including the use of rapid cooling with severe hemodilution and alkalosis. Inferences from these laboratory studies, together with an epidemic of choreoathetosis in the late 1980s, led to retrospective clinical studies and subsequently several prospective randomized clinical trials at Boston Children’s examining the neurodevelopmental consequences of various bypass manipulations. These early studies were conducted with the outstanding collaborative efforts of Dr. Jane Newburger and Dr. David Bellinger.
Since moving to Children’s National Dr. Jonas’ laboratory studies of neuroprotection have been conducted in conjunction with Dr. Vittorio Gallo, director of neuroscience research at Children’s National and Dr. Nobu Ishibashi, director of the cardiac surgery research laboratory. Their NIH supported studies have investigated the impact of congenital heart disease and cardiopulmonary bypass on the development of the brain, particularly white matter, in the individual with congenital heart disease.